Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Protalix BioTherapeutics CEO David Aviezer To Retire - Quick Facts

RELATED NEWS
Trade PLX now with 

Protalix BioTherapeutics Inc. (PLX: Quote) announced that David Aviezer has decided to retire after almost 12 years from his role as the Company's President and Chief Executive Officer. He will retire this year upon the completion of a process to nominate his successor.

In the meantime, Aviezer will continue serving as President and Chief Executive Officer and remains a member of the Board of Directors.

The company's Board will appoint a committee to select a new Chief Executive Officer.

Click here to receive FREE breaking news email alerts for Protalix BioTherapeutics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved sharply lower over the course of the trading day on Wednesday, adding to the modest weakness seen in the two previous sessions. With the losses on the day, the major averages fell to their lowest closing levels in over a month. Democrats have climbed into the lead on a generic ballot, according to the results of a new CNN/ORC International poll, although the results may not be as positive for the party as they first appear. With spending on private and public construction both showing notable decreases, the Commerce Department released a report on Wednesday showing an unexpected drop in U.S. construction spending in the month of August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.